Abstract: Techniques are described for developing and using applications and skills with autonomous vehicles. In some embodiments, a development platform is provided that enables access to a developer console for developing software modules for use with autonomous vehicles. For example, a developer can specify instructions for causing an autonomous vehicle to perform one or more operations. To control the behavior of an autonomous vehicle, the instructions can cause an executing computer system at the autonomous vehicle to generate calls to an application programming interface (API) associated with an autonomous navigation system of autonomous vehicle. Such calls to the API can be configured to adjust parameters of a behavioral objective associated with a trajectory generation process performed by the autonomous navigation system that controls the behavior of the autonomous vehicle. The instructions specified by the developer can be packaged as a software module that can be deployed for use at autonomous vehicle.

Abstract: A method includes receiving a training set of utterances for training a machine-learning model to identify one or more intents for one or more utterances, and augmenting the training set of utterances with out-of-domain (OOD) examples. The augmenting includes: generating a data set of OOD examples, filtering out OOD examples from the data set of OOD examples, determining a difficulty value for each OOD example remaining within the filtered data set of the OOD examples, and generating augmented batches of utterances including utterances from the training set of utterances and utterances from the filtered data set of the OOD based on the difficulty value for each OOD. Thereafter, the machine-learning model is trained using the augmented batches of utterances in accordance with a curriculum training protocol.

Abstract: The invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, L, X, Y and p are as defined in the description; to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. The compounds of Formula (I) may modulate the activity of antigens of interest and may be useful in inducing or enhancing an immune response against diseases, disorders and conditions mediated by antigens of interest.

Abstract: A pipe insulation is formed from multiple discrete sheets of fiberglass that are wetted with a binder composition. The sheets are spiral wound around a mandrel in a partially overlapping fashion. The wound sheets are further processed to interface with one another and form a unitary elongated cylinder. The binder in the elongated cylinder is then cured to form the pipe insulation.

Abstract: A method, computer system, and computer program product are provided for deploying software using a versioning schema. An n-dimensional string is obtained that describes a version of a component, wherein a value for each dimension describes a particular feature of the component. The n-dimensional string is analyzed using a template to determine each feature of the component. It is determined whether to deploy the version of the component based on the analyzing and based on criteria related to one or more features of the component.

Abstract: The present invention provides pharmaceutically active pyrrolo[2,3-d]pyrimidinyl and pyrrolo[2,3-d]pyridinyl acrylamides and analogues thereof. Such compounds are useful for inhibiting Janus Kinase (JAK). This invention also is directed to compositions comprising methods for making such compounds, and methods for treating and preventing conditions mediated by JAK.

Abstract: A method for 3D object perception is described. The method includes extracting features from each image of a synthetic stereo pair of images. The method also includes generating a low-resolution disparity image based on the features extracted from each image of the synthetic stereo pair images. The method further includes predicting, by a trained neural network, a feature map based on the low-resolution disparity image and one of the synthetic stereo pair of images. The method also includes generating, by a perception prediction head, a perception prediction of a detected 3D object based on the feature map predicted by the trained neural network.

Abstract: Techniques are disclosed herein for focused training of language models and end-to-end hypertuning of the framework. In one aspect, a method is provided that includes obtaining a machine learning model pre-trained for language modeling, and post-training the machine learning model for various tasks to generate a focused machine learning model. The post-training includes: (i) training the machine learning model on an unlabeled set of training data pertaining to a task that the machine learning model was pre-trained for as part of the language modeling, and the unlabeled set of training data is obtained with respect to a target domain, a target task, or a target language, and (ii) training the machine learning model on a labeled set of training data that pertains to another task that is an auxiliary task related to a downstream task to be performed using the machine learning model or output from the machine learning model.

Abstract: A method of forming a part includes 3D printing a photopolymerizable resin and forming a preformed part and subsequently post-curing the preformed part with electron beams. The preformed part may be cured via UV curing. A section of the preformed part post-cured with electron beams may have a thickness of at least 1.0 centimeter, for example, at least 2.0 centimeters or at least 3.0 centimeters. An electron beam dosage to post-cure the preformed part may be between 10 kilogray (kGy) and 100 kGy. The preformed part may be 3D printed using stereolithography (SLA), digital light processing (DLP) or material jetting (MJ) and the photopolymerizable resin may include at least one of an acrylate functional polymer and a methacrylate functional polymer. In the alternative, or in addition to, the photopolymerizable resin may include at least one of a urethane, a polyester, and a polyether.

Abstract: The disclosure relates to insecticidal toxin resistance management and screening of novel insecticidal toxins. One embodiment relates to the isolation, characterization, compositions, and methods of use relating to polynucleotides encoding novel insecticidal toxin receptors and the polypeptides encoded thereby. The polynucleotides and polypeptides are useful in identifying or designing novel insecticidal toxin receptor ligands including novel insecticidal toxins.

Abstract: In one aspect, the invention relates to an immunogenic composition comprising modified O-polysaccharide molecules derived from E. coli lipopolysaccharides and conjugates thereof. Multivalent vaccines may be prepared by combining two or more monovalent immunogenic compositions for different E. coli serotypes. In one embodiment, the modified O-polysaccharide molecules are produced by a recombinant bacterium that includes a wzz gene.

Abstract: Techniques for using logit values for classifying utterances and messages input to chatbot systems in natural language processing. A method can include a chatbot system receiving an utterance generated by a user interacting with the chatbot system. The chatbot system can input the utterance into a machine-learning model including a set of binary classifiers. Each binary classifier of the set of binary classifiers can be associated with a modified logit function. The method can also include the machine-learning model using the modified logit function to generate a set of distance-based logit values for the utterance. The method can also include the machine-learning model applying an enhanced activation function to the set of distance-based logit values to generate a predicted output. The method can also include the chatbot system classifying, based on the predicted output, the utterance as being associated with the particular class.

Abstract: In some aspects, a computing device may receive, at a data processing system, a set of utterances for training or inferencing with a named entity recognizer to assign a label to each token piece from the set of utterances. The computing device may determine a length of each utterance in the set and when the length of the utterance exceeds a pre-determined threshold of token pieces: dividing the utterance into a plurality of overlapping chunks of token pieces; assigning a label together with a confidence score for each token piece in a chunk; determining a final label and an associated confidence score for each chunk of token pieces by merging two confidence scores; determining a final annotated label for the utterance based at least on the merging the two confidence scores; and storing the final annotated label in a memory.

Abstract: Systems and methods for sterilization using nonthermal plasma (NTP) ionization are disclosed. An example method for inactivation of viable microorganisms includes: inactivating viable microorganisms in a predetermined volume by: installing a plurality of ceiling mounted direct current (DC) or alternating current (AC), bipolar or steady-state, ion emitter modules based on a geometry of the predetermined volume; and producing, using the plurality of ceiling mounted ion emitter modules, a DC or AC, bipolar or steady-state, nonthermal plasma (NTP), each of the ceiling mounted ion emitter modules comprising a high voltage power supply (HVPS).

Abstract: A system for positioning a patient before, during or after a medical procedure can include an arm assembly having a proximal end, an opposing distal end, and at least one joint therebetween. The joint can be configured to permit the distal end of the arm assembly to move with respect to the proximal end of the arm assembly. The proximal end of the arm assembly can be configured to be fixed with respect to a surgical table. The system can also include a ball joint mechanism attached to the distal end of the arm assembly and to a head support configured to support a patient's head. The ball joint mechanism can include a ball joint and a motor. Activation of the motor can permit or prevent movement of the ball joint.

Abstract: Techniques are disclosed herein for executing an execution plan for a digital assistant with generative artificial intelligence (genAI). A first genAI model can generate a list of executable actions based on an utterance provided by a user. An execution plan can be generated to include the executable actions. The execution plan can be executed by performing an iterative process for each of the executable actions. The iterative process can include identifying an action type, invoking one or more states, and executing, by the one or more states, the executable action using an asset to obtain an output. A second prompt can be generated based on the output obtained from executing each of the executable actions. A second genAI model can generate a response to the utterance based on the second prompt.

Abstract: Techniques are disclosed herein for implementing digital assistants using generative artificial intelligence. An input prompt comprising a natural language utterance and candidate agents and associated actions can be constructed. An execution plan can be generated using a first generative artificial model based on the input prompt. The execution plan can be executed to perform actions included in the execution plan using agents indicated by the execution plan. A response to the natural language utterance can be generated by a second generative artificial intelligence model using one or more outputs from executing the execution plan.

Abstract: This disclosure generally relates to USB TYPE-C, and, in particular, DISPLAYPORT Alternate Mode communication in a USB TYPE-C environment. In one embodiment, a device determines a DISPLAYPORT mode and determines an orientation of a USB TYPE-C connector plug. A multiplexer multiplexes a DISPLAYPORT transmission based in part on the determined orientation of the USB TYPE-C connector plug.

Abstract: Compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined herein, and salts thereof, that are useful as JAK kinase inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.